Massive french study aims to unlock secrets of rare MPS diseases
NCT ID NCT06036693
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study will follow up to 1,000 people in France with mucopolysaccharidosis (MPS), a group of rare genetic disorders. Researchers will collect medical data from patient records and ongoing checkups to map how the diseases progress and how current treatments affect symptoms. The goal is to improve future care and understanding of these conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide a clearer picture of how MPS diseases progress and how current treatments affect patients over the long term.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test new therapies, and results may take years to gather and analyze.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCOPOLYSACCHARIDOSIS I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
American Memorial Hospital
NOT_YET_RECRUITINGReims, France
-
Centre Hospitalier Universitaire d'Angers
RECRUITINGAngers, France
-
Centre Hospitalier de Pau
RECRUITINGPau, France
-
Clinique Monié
NOT_YET_RECRUITINGToulouse, France
-
Hôpital Armand Trousseau
RECRUITINGParis, France
-
Hôpital Beaujon
RECRUITINGClichy, France
-
Hôpital Brabois
RECRUITINGNancy, France
-
Hôpital Charles Nicolle
NOT_YET_RECRUITINGRouen, France
-
Hôpital Clocheville
RECRUITINGTours, France
-
Hôpital Gui de Chauliac
RECRUITINGMontpellier, France
-
Hôpital Jeanne de Flandre
RECRUITINGLille, France
-
Hôpital Morvan
RECRUITINGBrest, France
-
Hôpital Necker-Enfants Malades
RECRUITINGParis, France
-
Hôpital Pontchaillou
RECRUITINGRennes, France
-
Hôpital Raymond-Poincaré
NOT_YET_RECRUITINGGarches, France
-
Hôpital Robert Debré
RECRUITINGParis, France
-
Hôpital d'Estaing
NOT_YET_RECRUITINGClermont-Ferrand, France
-
Hôpital de Hautepierre
NOT_YET_RECRUITINGStrasbourg, France
-
Hôpital de la Croix Saint-Simon
NOT_YET_RECRUITINGParis, France
-
Hôpital de la Pitié-Salpêtrière
RECRUITINGParis, France
-
Hôpital de la Timone
RECRUITINGMarseille, France
-
Hôpital des Enfants
NOT_YET_RECRUITINGToulouse, France
-
Hôpital des Enfants - Groupe Hospitalier Pellegrin
NOT_YET_RECRUITINGBordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene Editing's lasting impact: a 10-Year safety watch
- Gene therapy watch: RGX-111 safety tracked in MPS i patients
- New registry aims to unlock secrets of rare childhood diseases
- Gene therapy breakthrough offers hope for boys with rare brain disease
- CBD trial aims to ease sanfilippo syndrome symptoms
- Major study tracks rare brain diseases to unlock their secrets